BioAlliance Pharma: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at November 28, 2008

PARIS--(BUSINESS WIRE)--Regulatory News: Pursuant to article L.233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority):
MORE ON THIS TOPIC